The Molecular Basis for Impaired Cerebral Myogenic Response in Type 2 Diabetes

atmire.migration.oldid3053
dc.contributor.advisorCole, William
dc.contributor.authorAbdelrahman, Khaled
dc.date.accessioned2015-04-06T21:23:47Z
dc.date.available2015-06-22T07:00:39Z
dc.date.issued2015-04-06
dc.date.submitted2015en
dc.description.abstractCognition and brain function are dependent on appropriate control of blood flow within the cerebral circulation. Cerebral blood flow is controlled through the interplay of several physiological mechanisms that regulate the contractility of vascular smooth muscle cells (VSMCs) within the wall of cerebral arteries. The myogenic response of cerebral arteries is a crucial mechanism that is responsible for maintaining adequate brain blood flow. This fundamental mechanism is due to cellular processes intrinsic to VSMCs including: 1) Ca2+-calmodulin-dependent activation of myosin light chain kinase and phosphorylation of LC20, 2) Rho-associated kinase (ROK)-dependent phosphorylation of myosin phosphatase targeting subunit 1 (MYPT1) and suppression of myosin light chain phosphatase activity, and 3) dynamic reorganization of the actin cytoskeleton. Inappropriate regulation of one or more of these mechanisms may contribute to the dysfunctional control of cerebral diameter and flow, predisposing type 2 diabetic patients to ischemic and hemorrhagic stroke. Here, we employed Goto-Kakizaki (GK) rats, a type 2 diabetic rat model, to identify the molecular basis for the dysfunctional myogenic constriction in early and established type 2 diabetes. We detected an enhanced basal myogenic tone in prediabetic GK cerebral arteries at low intraluminal pressure that progressed with the severity of diabetes such that the myogenic response was lost in arteries of GK rats with established diabetes. Our biochemical evidence shows that there are parallel, progressive alterations in MYPT1 and LC20 phosphorylation, as well as actin polymerization downstream of ROK that are consistent with the evolution of dysfunctional myogenic response. These findings provide a better understanding of the underlying defects responsible for dysfunctional control of cerebral arterial diameter and blood flow in type 2 diabetes.en_US
dc.identifier.citationAbdelrahman, K. (2015). The Molecular Basis for Impaired Cerebral Myogenic Response in Type 2 Diabetes (Doctoral thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/28249en_US
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/28249
dc.identifier.urihttp://hdl.handle.net/11023/2132
dc.language.isoeng
dc.publisher.facultyGraduate Studies
dc.publisher.institutionUniversity of Calgaryen
dc.publisher.placeCalgaryen
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectBiology--Molecular
dc.subjectPhysiology
dc.subjectPharmacology
dc.subject.classificationMyogenic responseen_US
dc.subject.classificationType 2 diabetesen_US
dc.subject.classificationCerebral arteriesen_US
dc.subject.classificationVascular smooth muscle cellsen_US
dc.subject.classificationGoto-Kakizakien_US
dc.titleThe Molecular Basis for Impaired Cerebral Myogenic Response in Type 2 Diabetes
dc.typedoctoral thesis
thesis.degree.disciplineCardiovascular & Respiratory Sciences
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameDoctor of Philosophy (PhD)
ucalgary.item.requestcopytrue
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ucalgary_2015_Abdelrahman_Khaled.pdf
Size:
4 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.65 KB
Format:
Item-specific license agreed upon to submission
Description: